Abercorn Rehabilitation Center | |
11800 Abercorn Street, Savannah, Georgia 31419 | |
(912) 925-4402 | |
Name | Abercorn Rehabilitation Center |
---|---|
Location | 11800 Abercorn Street, Savannah, Georgia |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 100 |
Occupancy Rate | 68.1% |
Medicare ID (CCN) | 115132 |
Legal Business Name | Abercorn Rehabilitation Center Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1164848396 |
Organization Name | ABERCORN REHABILITATION CENTER, LLC |
Doing Business As | ABERCORN REHABILITATION CENTER |
Address | 11800 Abercorn St, Savannah, GA 31419 |
Phone Number | 912-925-4402 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe Alzheimer's disease, a combination therapy that delays nursing home admission at 19 months would earn 43 percent patient share, according to surveyed U.S. neurologists. In comparison, in Europe, such an agent would earn a slightly lower patient share of 30 percent, according to surveyed European neurologists. This lower share estimate is possibly a result of higher price sensitivity of European markets.
In middle aged populations, the risks of cardiovascular conditions are progressively lower the longer a person's parents lived past 69 years old, according to a study of 186,000 participants using a voluntary database published today in the Journal of the American College of Cardiology.
Nine days before the South Carolina primary, Mitt Romney has 'picked up his pro-life rhetoric' as Newt Gingrich goes on the attack.
Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports.
IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe Alzheimer's disease, a combination therapy that delays nursing home admission at 19 months would earn 43 percent patient share, according to surveyed U.S. neurologists. In comparison, in Europe, such an agent would earn a slightly lower patient share of 30 percent, according to surveyed European neurologists. This lower share estimate is possibly a result of higher price sensitivity of European markets.
In middle aged populations, the risks of cardiovascular conditions are progressively lower the longer a person's parents lived past 69 years old, according to a study of 186,000 participants using a voluntary database published today in the Journal of the American College of Cardiology.
Nine days before the South Carolina primary, Mitt Romney has 'picked up his pro-life rhetoric' as Newt Gingrich goes on the attack.
Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports.
IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 8 | 14.46 |
Percentage of long-stay residents who lose too much weight | 9.45 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 47.13 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 7.35 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 6.53 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.79 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.67 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 13.36 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.88 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 10.69 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.18 | 95.98 |
Percentage of short-stay residents who made improvements in function | 84.06 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 81.87 | 82.93 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe Alzheimer's disease, a combination therapy that delays nursing home admission at 19 months would earn 43 percent patient share, according to surveyed U.S. neurologists. In comparison, in Europe, such an agent would earn a slightly lower patient share of 30 percent, according to surveyed European neurologists. This lower share estimate is possibly a result of higher price sensitivity of European markets.
In middle aged populations, the risks of cardiovascular conditions are progressively lower the longer a person's parents lived past 69 years old, according to a study of 186,000 participants using a voluntary database published today in the Journal of the American College of Cardiology.
Nine days before the South Carolina primary, Mitt Romney has 'picked up his pro-life rhetoric' as Newt Gingrich goes on the attack.
Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports.
IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.
› Verified 3 days ago
Signature Healthcare Of Savannah Location: 815 East 63 Street, Savannah, Georgia 31405 Phone: (912) 352-8615 | |
Abercorn Rehabilitation Center Location: 11800 Abercorn Street, Savannah, Georgia 31419 Phone: (912) 925-4402 | |
Pruitthealth - Savannah Location: 12825 White Bluff Road, Savannah, Georgia 31419 Phone: (912) 927-9416 | |
Savannah Square Health Center Location: 1 Savannah Square Drive, Savannah, Georgia 31406 Phone: (912) 927-7550 | |
Candler Skilled Nursing Unit Location: 5353 Reynolds Street, Savannah, Georgia 31405 Phone: (912) 819-6262 |